Macrophage metalloelastase (MMP-12) as a target for inflammatory respiratory diseases

Vincent Lagente1, Catherine Le Quement, Elisabeth Boichot

  • 1Université de Rennes I, INSERM U620/EA MDC, 2, avenue du Pr. Léon Bernard, 35043 Rennes Cedex, France. vincent.lagente@univ-rennes1.fr

Abstract

Insights

Macrophage elastase (MMP-12) is crucial in lung tissue remodeling and inflammation, particularly in chronic obstructive pulmonary diseases (COPD). Inhibiting MMP-12 shows promise for treating inflammatory respiratory disorders like COPD.

Area of Science:

  • Pulmonary Medicine
  • Biochemistry

Background:

  • Matrix metalloproteinases (MMPs) regulate extracellular matrix turnover, implicated in lung tissue remodeling.
  • Macrophage elastase (MMP-12) degrades elastin and contributes to tissue remodeling in inflammatory respiratory diseases like COPD and emphysema.

Purpose of the Study:

  • To review the role of MMP-12 in respiratory disease pathophysiology.
  • To propose MMP-12 as a therapeutic target for inflammatory respiratory disorders.

Main Methods:

  • Review of existing literature on MMP-12 function in respiratory diseases.
  • Analysis of studies involving MMP-12 inhibitors in preclinical models.

Main Results:

  • MMP-12 is involved in the inflammatory processes associated with cigarette smoke exposure.
  • Studies using MMP-12 inhibitors have shown reduced inflammation and airspace enlargement in lung tissue.

Conclusions:

  • MMP-12 plays a significant role in cigarette smoke-induced inflammation.
  • MMP-12 represents a potential therapeutic target for treating COPD.